ArticleFood & function2018

Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models.

Ran Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.